Topic: Convalescent Plasma

During an NPR segment, Dr. Arturo Casadevall of Johns Hopkins discussed COVID-19 treatments like Remdesivir and monoclonal antibodies while completely avoiding any mention of Ivermectin. The hosts criticize the expert for omitting a widely discussed alternative treatment. They suggest that the media is intentionally suppressing information that could help patients recover outside of hospitals.

The Red Cross announced that individuals who have received a COVID-19 vaccine cannot donate convalescent plasma to treat other patients. The policy is based on the claim that the vaccine may interfere with the specific antibodies needed for effective treatment. This has sparked a debate about whether vaccines "wipe out" the robust natural immunity gained from prior infection, potentially forcing people onto a permanent vaccine "treadmill."

Blood banks are reporting a significant decline in convalescent plasma donations as more people receive COVID-19 vaccinations. Once an individual is vaccinated, their plasma is generally no longer used for convalescent treatment because the antibodies are vaccine-induced rather than from natural recovery. This creates a potential supply issue for hospitalized patients who rely on plasma therapy.

The Trump administration has declined to join a global vaccine development effort involving the World Health Organization. Domestically, a panel at the National Institutes of Health (NIH) stated there is insufficient evidence for convalescent plasma as a "standard of care," contradicting the FDA's emergency use authorization. The hosts analyze how media outlets like Democracy Now frame these conflicting medical reports.